Is cancer a metabolic rebellion against host aging? In the quest for immortality, tumor cells try to save themselves by boosting mitochondrial metabolism

References

• Blagosklonny MV. Cell immortality and hallmarks of cancer. Cell Cycle 2003; 2:296 - 299; PMID: 12851477; http://dx.doi.org/10.4161/cc.2.4.470
   PubMed Web of Science ®Google Scholar
• Blagosklonny MV. Paradoxes of aging. Cell Cycle 2007; 6:2997 - 3003; PMID: 18156807; http://dx.doi.org/10.4161/cc.6.24.5124
   PubMed Web of Science ®Google Scholar
• Blagosklonny MV. Program-like aging and mitochondria: instead of random damage by free radicals. J Cell Biochem 2007; 102:1389 - 1399; PMID: 17975792; http://dx.doi.org/10.1002/jcb.21602
   PubMed Web of Science ®Google Scholar
• Blagosklonny MV. Prevention of cancer by inhibiting aging. Cancer Biol Ther 2008; 7:1520 - 1524; PMID: 18769112; http://dx.doi.org/10.4161/cbt.7.10.6663
   PubMed Web of Science ®Google Scholar
• Blagosklonny MV. Validation of anti-aging drugs by treating age-related diseases. Aging (Albany NY) 2009; 1:281 - 288; PMID: 20157517
   PubMedGoogle Scholar
• Blagosklonny MV. TOR-driven aging: speeding car without brakes. Cell Cycle 2009; 8:4055 - 4059; PMID: 19923900; http://dx.doi.org/10.4161/cc.8.24.10310
   PubMed Web of Science ®Google Scholar
• Blagosklonny MV. Aging-suppressants: cellular senescence (hyperactivation) and its pharmacologic deceleration. Cell Cycle 2009; 8:1883 - 1887; PMID: 19448395; http://dx.doi.org/10.4161/cc.8.12.8815
   PubMed Web of Science ®Google Scholar
• Blagosklonny MV, Campisi J. Cancer and aging: more puzzles, more promises?. Cell Cycle 2008; 7:2615 - 2618; PMID: 18719390; http://dx.doi.org/10.4161/cc.7.17.6626
   PubMed Web of Science ®Google Scholar
• Blagosklonny MV, Campisi J, Sinclair DA. Aging: past, present and future. Aging (Albany NY) 2009; 1:1 - 5; PMID: 20157590
   PubMedGoogle Scholar
• Blagosklonny MV, Hall MN. Growth and aging: a common molecular mechanism. Aging (Albany NY) 2009; 1:357 - 362; PMID: 20157523
   PubMedGoogle Scholar
• Fleg JL, Morrell CH, Bos AG, Brant LJ, Talbot LA, Wright JG, et al. Accelerated longitudinal decline of aerobic capacity in healthyears older adults. Circulation 2005; 112:674 - 682; PMID: 16043637
   PubMed Web of Science ®Google Scholar
• Hollenberg M, Yang J, Haight TJ, Tager IB. Longitudinal changes in aerobic capacity: implications for concepts of aging. J Gerontol A Biol Sci Med Sci 2006; 61:851 - 858; PMID: 16912104; http://dx.doi.org/10.1093/gerona/61.8.851
   PubMed Web of Science ®Google Scholar
• Tanaka H, Desouza CA, Jones PP, Stevenson ET, Davy KP, Seals DR. Greater rate of decline in maximal aerobic capacity with age in physically active vs. sedentary healthy women. J Appl Physiol 1997; 83:1947 - 1953; PMID: 9390967
   PubMed Web of Science ®Google Scholar
• Ross JM, Oberg J, Brene S, Coppotelli G, Terzioglu M, Pernold K, et al. High brain lactate is a hallmark of aging and caused by a shift in the lactate dehydrogenase A/B ratio. Proc Natl Acad Sci USA 2010; 107:20087 - 20092; PMID: 21041631; http://dx.doi.org/10.1073/pnas.1008189107
   PubMed Web of Science ®Google Scholar
• Bittles AH, Harper N. Increased glycolysis in aging cultured human diploid fibroblasts. Biosci Rep 1984; 4:751 - 756; PMID: 6509159; http://dx.doi.org/10.1007/BF01128816
   PubMed Web of Science ®Google Scholar
• Goldstein S, Ballantyne SR, Robson AL, Moerman EJ. Energy metabolism in cultured human fibroblasts during aging in vitro. J Cell Physiol 1982; 112:419 - 424; PMID: 6127343; http://dx.doi.org/10.1002/jcp.1041120316
   PubMed Web of Science ®Google Scholar
• Sotgia F, Martinez-Outschoorn UE, Howell A, Pestell RG, Pavlides S, Lisanti MP. Caveolin-1 and Cancer Metabolism in Tumor Progression: Markers, Models and Mechanisms. Annu Rev Pathol 2012; 7:423 - 467
   PubMed Web of Science ®Google Scholar
• Sotgia F, Martinez-Outschoorn UE, Lisanti MP. Mitochondrial oxidative stress drives tumor progression and metastasis: should we use antioxidants as a key component of cancer treatment and prevention?. BMC Med 2011; 9:62; PMID: 21605374; http://dx.doi.org/10.1186/1741-7015-9-62
   PubMed Web of Science ®Google Scholar
• Sotgia F, Martinez-Outschoorn UE, Pavlides S, Howell A, Pestell RG, Lisanti MP. Understanding the Warburg effect and the prognostic value of stromal caveolin-1 as a marker of a lethal tumor microenvironment. Breast Cancer Res 2011; 13:213; PMID: 21867571; http://dx.doi.org/10.1186/bcr2892
   PubMed Web of Science ®Google Scholar
• Martinez-Outschoorn UE, Pavlides S, Howell A, Pestell RG, Tanowitz HB, Sotgia F, et al. Stromal-epithelial metabolic coupling in cancer: integrating autophagy and metabolism in the tumor microenvironment. Int J Biochem Cell Biol 2011; 43:1045 - 1051; PMID: 21300172; http://dx.doi.org/10.1016/j.biocel.2011.01.023
   PubMed Web of Science ®Google Scholar
• Martinez-Outschoorn UE, Whitaker-Menezes D, Pavlides S, Chiavarina B, Bonuccelli G, Casey T, et al. The autophagic tumor stroma model of cancer or “battery-operated tumor growth”: A simple solution to the autophagy paradox. Cell Cycle 2010; 9:4297 - 4306; PMID: 21051947; http://dx.doi.org/10.4161/cc.9.21.13817
   PubMed Web of Science ®Google Scholar
• Pavlides S, Vera I, Gandara R, Sneddon S, Pestell R, Mercier I, et al. Warburg Meets Autophagy: Cancer Associated Fibroblasts Accelerate Tumor Growth and Metastasis Via Oxidative Stress, Mitophagy and Aerobic Glycolysis. Antioxid Redox Signal 2011; In press PMID: 21883043
   PubMed Web of Science ®Google Scholar
• Martinez-Outschoorn UE, Pestell RG, Howell A, Nagajyothi F, Machado FS, Tanowitz HB, et al. Energy transfer in “parasitic” cancer metabolism: Mitochondria are the powerhouse and Achilles' heel of tumor cells. Cell Cycle 2011; 10:4208 - 4216; PMID: 22033146
   PubMed Web of Science ®Google Scholar
• Rebbeck CA, Thomas R, Breen M, Leroi AM, Burt A. Origins and evolution of a transmissible cancer. Evolution 2009; 63:2340 - 2349; PMID: 19453727; http://dx.doi.org/10.1111/j.1558-5646.2009.00724.x
   PubMed Web of Science ®Google Scholar
• Murchison EP. Clonally transmissible cancers in dogs and Tasmanian devils. Oncogene 2008; 27:19 - 30; PMID: 19956175; http://dx.doi.org/10.1038/onc.2009.350
   PubMedGoogle Scholar
• Rebbeck CA, Leroi AM, Burt A. Mitochondrial capture by a transmissible cancer. Science 2011; 331:303; PMID: 21252340; http://dx.doi.org/10.1126/science.1197696
   PubMed Web of Science ®Google Scholar
• Spees JL, Olson SD, Whitney MJ, Prockop DJ. Mitochondrial transfer between cells can rescue aerobic respiration. Proc Natl Acad Sci USA 2006; 103:1283 - 1288; PMID: 16432190; http://dx.doi.org/10.1073/pnas.0510511103
   PubMed Web of Science ®Google Scholar
• Berridge MV, Tan AS. Mitochondrial Gene Transfer to Transplantable Tumors Lacking a Mitochondrial Genome. Rejuvenation Res 2011; 14:13
   Google Scholar
• Martinez-Outschoorn UE, Pavlides S, Whitaker-Menezes D, Daumer KM, Milliman JN, Chiavarina B, et al. Tumor cells induce the cancer associated fibroblast phenotype via caveolin-1 degradation: implications for breast cancer and DCIS therapy with autophagy inhibitors. Cell Cycle 2010; 9:2423 - 2433; PMID: 20562526; http://dx.doi.org/10.4161/cc.9.12.12048
   PubMed Web of Science ®Google Scholar
• Martinez-Outschoorn UE, Lin Z, Trimmer C, Flomenberg N, Wang C, Pavlides S, et al. Cancer cells metabolically “fertilize” the tumor microenvironment with hydrogen peroxide, driving the Warburg effect: implications for PET imaging of human tumors. Cell Cycle 2011; 10:2504 - 2520; PMID: 21778829; http://dx.doi.org/10.4161/cc.10.15.16585
   PubMed Web of Science ®Google Scholar
• Lisanti MP, Martinez-Outschoorn UE, Lin Z, Pavlides S, Whitaker-Menezes D, Pestell RG, et al. Hydrogen peroxide fuels aging, inflammation, cancer metabolism and metastasis: the seed and soil also needs “fertilizer”. Cell Cycle 2011; 10:2440 - 2449; PMID: 21734470; http://dx.doi.org/10.4161/cc.10.15.16870
   PubMed Web of Science ®Google Scholar
• Lisanti MP, Martinez-Outschoorn UE, Pavlides S, Whitaker-Menezes D, Pestell RG, Howell A, et al. Accelerated aging in the tumor microenvironment: connecting aging, inflammation and cancer metabolism with personalized medicine. Cell Cycle 2011; 10:2059 - 2063; PMID: 21654190; http://dx.doi.org/10.4161/cc.10.13.16233
   PubMed Web of Science ®Google Scholar
• Martinez-Outschoorn UE, Balliet RM, Rivadeneira DB, Chiavarina B, Pavlides S, Wang C, et al. Oxidative stress in cancer associated fibroblasts drives tumor-stroma co-evolution: A new paradigm for understanding tumor metabolism, the field effect and genomic instability in cancer cells. Cell Cycle 2010; 9:3256 - 3276; PMID: 20814239; http://dx.doi.org/10.4161/cc.9.16.12553
   PubMed Web of Science ®Google Scholar
• Martinez-Outschoorn UE, Trimmer C, Lin Z, Whitaker-Menezes D, Chiavarina B, Zhou J, et al. Autophagy in cancer associated fibroblasts promotes tumor cell survival: Role of hypoxia, HIF1 induction and NFkappaB activation in the tumor stromal microenvironment. Cell Cycle 2010; 9:3515 - 3533; PMID: 20855962; http://dx.doi.org/10.4161/cc.9.17.12928
   PubMed Web of Science ®Google Scholar
• Martinez-Outschoorn UE, Whitaker-Menezes D, Lin Z, Flomenberg N, Howell A, Pestell RG, et al. Cytokine production and inflammation drive autophagy in the tumor microenvironment: role of stromal caveolin-1 as a key regulator. Cell Cycle 2011; 10:1784 - 1793; PMID: 21566463; http://dx.doi.org/10.4161/cc.10.11.15674
   PubMed Web of Science ®Google Scholar
• Chiavarina B, Whitaker-Menezes D, Migneco G, Martinez-Outschoorn UE, Pavlides S, Howell A, et al. HIF1-alpha functions as a tumor promoter in cancer associated fibroblasts, and as a tumor suppressor in breast cancer cells: Autophagy drives compartment-specific oncogenesis. Cell Cycle 2010; 9:3534 - 3551; PMID: 20864819; http://dx.doi.org/10.4161/cc.9.17.12908
   PubMed Web of Science ®Google Scholar
• Pavlides S, Whitaker-Menezes D, Castello-Cros R, Flomenberg N, Witkiewicz AK, Frank PG, et al. The reverse Warburg effect: aerobic glycolysis in cancer associated fibroblasts and the tumor stroma. Cell Cycle 2009; 8:3984 - 4001; PMID: 19923890; http://dx.doi.org/10.4161/cc.8.23.10238
   PubMed Web of Science ®Google Scholar
• Pavlides S, Tsirigos A, Migneco G, Whitaker-Menezes D, Chiavarina B, Flomenberg N, et al. The autophagic tumor stroma model of cancer: Role of oxidative stress and ketone production in fueling tumor cell metabolism. Cell Cycle 2010; 9:3485 - 3505; PMID: 20861672; http://dx.doi.org/10.4161/cc.9.17.12721
   PubMed Web of Science ®Google Scholar
• Pavlides S, Tsirigos A, Vera I, Flomenberg N, Frank PG, Casimiro MC, et al. Loss of stromal caveolin-1 leads to oxidative stress, mimics hypoxia and drives inflammation in the tumor microenvironment, conferring the “reverse Warburg effect”: a transcriptional informatics analysis with validation. Cell Cycle 2010; 9:2201 - 2219; PMID: 20519932; http://dx.doi.org/10.4161/cc.9.11.11848
   PubMed Web of Science ®Google Scholar
• Pavlides S, Tsirigos A, Vera I, Flomenberg N, Frank PG, Casimiro MC, et al. Transcriptional evidence for the “Reverse Warburg Effect” in human breast cancer tumor stroma and metastasis: similarities with oxidative stress, inflammation, Alzheimer's disease and “Neuron-Glia Metabolic Coupling”. Aging (Albany NY) 2010; 2:185 - 199; PMID: 20442453
   PubMedGoogle Scholar
• Martinez-Outschoorn UE, Prisco M, Ertel A, Tsirigos A, Lin Z, Pavlides S, et al. Ketones and lactate increase cancer cell “stemness,” driving recurrence, metastasis and poor clinical outcome in breast cancer: achieving personalized medicine via Metabolo-Genomics. Cell Cycle 2011; 10:1271 - 1286; PMID: 21512313; http://dx.doi.org/10.4161/cc.10.8.15330
   PubMed Web of Science ®Google Scholar
• Martinez-Outschoorn UE, Lin Z, Ko YH, Goldberg AF, Flomenberg N, Wang C, et al. Understanding the metabolic basis of drug resistance: Therapeutic induction of the Warburg effect kills cancer cells. Cell Cycle 2011; 10:2521 - 2528; PMID: 21768775; http://dx.doi.org/10.4161/cc.10.15.16584
   PubMed Web of Science ®Google Scholar
• Martinez-Outschoorn UE, Goldberg A, Lin Z, Ko YH, Flomenberg N, Wang C, et al. Anti-estrogen resistance in breast cancer is induced by the tumor microenvironment and can be overcome by inhibiting mitochondrial function in epithelial cancer cells. Cancer Biol Ther 2011; 12:924 - 938; PMID: 22041887; http://dx.doi.org/10.4161/cbt.12.10.17780
   PubMed Web of Science ®Google Scholar
• Bonuccelli G, Tsirigos A, Whitaker-Menezes D, Pavlides S, Pestell RG, Chiavarina B, et al. Ketones and lactate “fuel” tumor growth and metastasis: Evidence that epithelial cancer cells use oxidative mitochondrial metabolism. Cell Cycle 2010; 9:3506 - 3514; PMID: 20818174; http://dx.doi.org/10.4161/cc.9.17.12731
   PubMed Web of Science ®Google Scholar
• Bonuccelli G, Whitaker-Menezes D, Castello-Cros R, Pavlides S, Pestell RG, Fatatis A, et al. The reverse Warburg effect: glycolysis inhibitors prevent the tumor promoting effects of caveolin-1 deficient cancer associated fibroblasts. Cell Cycle 2010; 9:1960 - 1971; PMID: 20495363; http://dx.doi.org/10.4161/cc.9.10.11601
   PubMed Web of Science ®Google Scholar
• Ni Chonghaile T, Sarosiek KA, Vo TT, Ryan JA, Tammareddi A, Moore Vdel G, et al. Pretreatment mitochondrial priming correlates with clinical response to cytotoxic chemotherapy. Science 2011; 334:1129 - 1133; PMID: 22033517; http://dx.doi.org/10.1126/science.1206727
   PubMed Web of Science ®Google Scholar
• El-Mir MY, Nogueira V, Fontaine E, Averet N, Rigoulet M, Leverve X. Dimethylbiguanide inhibits cell respiration via an indirect effect targeted on the respiratory chain complex I. J Biol Chem 2000; 275:223 - 228; PMID: 10617608; http://dx.doi.org/10.1074/jbc.275.1.223
   PubMed Web of Science ®Google Scholar
• Libby G, Donnelly LA, Donnan PT, Alessi DR, Morris AD, Evans JM. New users of metformin are at low risk of incident cancer: a cohort study among people with type 2 diabetes. Diabetes Care 2009; 32:1620 - 1625; PMID: 19564453; http://dx.doi.org/10.2337/dc08-2175
   PubMed Web of Science ®Google Scholar
• Jiralerspong S, Palla SL, Giordano SH, Meric-Bernstam F, Liedtke C, Barnett CM, et al. Metformin and pathologic complete responses to neoadjuvant chemotherapy in diabetic patients with breast cancer. J Clin Oncol 2009; 27:3297 - 3302; PMID: 19487376; http://dx.doi.org/10.1200/JCO.2009.19.6410
   PubMed Web of Science ®Google Scholar
• Phoenix KN, Vumbaca F, Fox MM, Evans R, Claffey KP. Dietary energy availability affects primary and metastatic breast cancer and metformin efficacy. Breast Cancer Res Treat 2010; 123:333 - 344; PMID: 20204498; http://dx.doi.org/10.1007/s10549-009-0647-z
   PubMed Web of Science ®Google Scholar
• Riccio A, Del Prato S, Vigili de Kreutzenberg S, Tiengo A. Glucose and lipid metabolism in non-insulin-dependent diabetes. Effect of metformin. Diabete Metab 1991; 17:180 - 184; PMID: 1936473
   PubMed Web of Science ®Google Scholar
• Zakikhani M, Dowling RJ, Sonenberg N, Pollak MN. The effects of adiponectin and metformin on prostate and colon neoplasia involve activation of AMP-activated protein kinase. Cancer Prev Res (Phila) 2008; 1:369 - 375; PMID: 19138981; http://dx.doi.org/10.1158/1940-6207.CAPR-08-0081
   PubMed Web of Science ®Google Scholar
• Reliene R, Schiestl RH. Antioxidant N-acetyl cysteine reduces incidence and multiplicity of lymphoma in Atm deficient mice. DNA Repair (Amst) 2006; 5:852 - 859; PMID: 16781197; http://dx.doi.org/10.1016/j.dnarep.2006.05.003
   PubMed Web of Science ®Google Scholar
• Flurkey K, Astle CM, Harrison DE. Life extension by diet restriction and N-acetyl-L-cysteine in genetically heterogeneous mice. J Gerontol A Biol Sci Med Sci 2010; 65:1275 - 1284; PMID: 20819793; http://dx.doi.org/10.1093/gerona/glq155
   PubMed Web of Science ®Google Scholar
• Brack C, Bechter-Thuring E, Labuhn M. N-acetylcysteine slows down aging and increases the life span of Drosophila melanogaster. Cell Mol Life Sci 1997; 53:960 - 966; PMID: 9447249; http://dx.doi.org/10.1007/PL00013199
   PubMed Web of Science ®Google Scholar
• Xu D, Finkel T. A role for mitochondria as potential regulators of cellular life span. Biochem Biophys Res Commun 2002; 294:245 - 248; PMID: 12051701; http://dx.doi.org/10.1016/S0006-291X(02)00464-3
   PubMed Web of Science ®Google Scholar
• Bulterijs S. Metformin as a geroprotector. Rejuvenation Res 2011; 14:469 - 482; PMID: 21882902; http://dx.doi.org/10.1089/rej.2011.1153
   PubMed Web of Science ®Google Scholar
• Anisimov VN, Berstein LM, Popovich IG, Zabezhinski MA, Egormin PA, Piskunova TS, et al. If started early in life, metformin treatment increases life span and postpones tumors in female SHR mice. Aging (Albany NY) 2011; 3:148 - 157; PMID: 21386129
   PubMedGoogle Scholar
• Anisimov VN, Piskunova TS, Popovich IG, Zabezhinski MA, Tyndyk ML, Egormin PA, et al. Gender differences in metformin effect on aging, life span and spontaneous tumorigenesis in 129/Sv mice. Aging (Albany NY) 2010; 2:945 - 958; PMID: 21164223
   PubMedGoogle Scholar
• Anisimov VN. Metformin for aging and cancer prevention. Aging (Albany NY) 2010; 2:760 - 774; PMID: 21084729
   PubMedGoogle Scholar
• Mouchiroud L, Molin L, Dalliere N, Solari F. Life span extension by resveratrol, rapamycin and metformin: The promise of dietary restriction mimetics for an healthy aging. Biofactors 2010; 36:377 - 382; PMID: 20848587; http://dx.doi.org/10.1002/biof.127
   PubMed Web of Science ®Google Scholar
• Anisimov VN, Egormin PA, Piskunova TS, Popovich IG, Tyndyk ML, Yurova MN, et al. Metformin extends life span of HER-2/neu transgenic mice and in combination with melatonin inhibits growth of transplantable tumors in vivo. Cell Cycle 2010; 9:188 - 197; PMID: 20016287; http://dx.doi.org/10.4161/cc.9.1.10407
   PubMed Web of Science ®Google Scholar
• Anisimov VN, Berstein LM, Egormin PA, Piskunova TS, Popovich IG, Zabezhinski MA, et al. Metformin slows down aging and extends life span of female SHR mice. Cell Cycle 2008; 7:2769 - 2773; PMID: 18728386; http://dx.doi.org/10.4161/cc.7.17.6625
   PubMed Web of Science ®Google Scholar
• Anisimov VN, Egormin PA, Bershtein LM, Zabezhinskii MA, Piskunova TS, Popovich IG, et al. Metformin decelerates aging and development of mammary tumors in HER-2/neu transgenic mice. Bull Exp Biol Med 2005; 139:721 - 723; PMID: 16224592; http://dx.doi.org/10.1007/s10517-005-0389-9
   PubMed Web of Science ®Google Scholar
• Anisimov VN, Berstein LM, Egormin PA, Piskunova TS, Popovich IG, Zabezhinski MA, et al. Effect of metformin on life span and on the development of spontaneous mammary tumors in HER-2/neu transgenic mice. Exp Gerontol 2005; 40:685 - 693; PMID: 16125352; http://dx.doi.org/10.1016/j.exger.2005.07.007
   PubMed Web of Science ®Google Scholar
• Inoue S, Hasegawa K, Ito S, Wakamatsu K, Fujita K. Antimelanoma activity of chloroquine, an antimalarial agent with high affinity for melanin. Pigment Cell Res 1993; 6:354 - 358; PMID: 8302774; http://dx.doi.org/10.1111/j.1600-0749.1993.tb00613.x
   PubMedGoogle Scholar
• Paget S. The distribution of secondary growths in cancer of the breast. Lancet 1889; 133:571 - 573; http://dx.doi.org/10.1016/S0140-6736(00)49915-0
   Google Scholar
• Hart IR. ‘Seed and soil’ revisited: mechanisms of site-specific metastasis. Cancer Metastasis Rev 1982; 1:5 - 16; PMID: 6764375; http://dx.doi.org/10.1007/BF00049477
   PubMedGoogle Scholar
• Hart IR, Fidler IJ. Role of organ selectivity in the determination of metastatic patterns of B16 melanoma. Cancer Res 1980; 40:2281 - 2287; PMID: 7388794
   PubMed Web of Science ®Google Scholar
• Hart IR, Talmadge JE, Fidler IJ. Metastatic behavior of a murine reticulum cell sarcoma exhibiting organ-specific growth. Cancer Res 1981; 41:1281 - 1287; PMID: 7011533
   PubMed Web of Science ®Google Scholar
• Nieman KM, Kenny HA, Penicka CV, Ladanyi A, Buell-Gutbrod R, Zillhardt MR, et al. Adipocytes promote ovarian cancer metastasis and provide energy for rapid tumor growth. Nat Med 2011; 17:1498 - 1503; PMID: 22037646; http://dx.doi.org/10.1038/nm.2492
   PubMed Web of Science ®Google Scholar
• Whitaker-Menezes D, Martinez-Outschoorn UE, Flomenberg N, Birbe RC, Witkiewicz AK, Howell A, et al. Hyperactivation of Oxidative Mitochondrial Metabolism in Epithelial Cancer Cells In Situ: Visualizing the Therapeutic Effects of Metformin in Tumor Tissue. Cell Cycle 2011; 10:4047 - 4064; PMID: 22134189
   PubMed Web of Science ®Google Scholar
• Sahin E, Colla S, Liesa M, Moslehi J, Muller FL, Guo M, et al. Telomere dysfunction induces metabolic and mitochondrial compromise. Nature 2011; 470:359 - 365; PMID: 21307849; http://dx.doi.org/10.1038/nature09787
   PubMed Web of Science ®Google Scholar
• David R. aging: Mitochondria and telomeres come together. Nat Rev Mol Cell Biol 2011; 12:204; PMID: 21407239; http://dx.doi.org/10.1038/nrm3082
   PubMed Web of Science ®Google Scholar
• Kelly DP. Cell biology: aging theories unified. Nature 2011; 470:342 - 343; PMID: 21307852; http://dx.doi.org/10.1038/nature09896
   PubMed Web of Science ®Google Scholar
• Finkel T. Telomeres and mitochondrial function. Circ Res 2011; 108:903 - 904; PMID: 21493920; http://dx.doi.org/10.1161/RES.0b013e31821bc2d8
   PubMed Web of Science ®Google Scholar
• Buzzai M, Jones RG, Amaravadi RK, Lum JJ, DeBerardinis RJ, Zhao F, et al. Systemic treatment with the antidiabetic drug metformin selectively impairs p53-deficient tumor cell growth. Cancer Res 2007; 67:6745 - 6752; PMID: 17638885; http://dx.doi.org/10.1158/0008-5472.CAN-06-4447
   PubMed Web of Science ®Google Scholar
• Bhalla K, Hwang BJ, Dewi RE, Ou L, Twaddel W, Fang HB, et al. PGC1alpha Promotes Tumor Growth by Inducing Gene Expression Programs Supporting Lipogenesis. Cancer Res 2011; 71:6888 - 6898; PMID: 21914785; http://dx.doi.org/10.1158/0008-5472.CAN-11-1011
   PubMed Web of Science ®Google Scholar
• Shiota M, Yokomizo A, Tada Y, Inokuchi J, Tatsugami K, Kuroiwa K, et al. Peroxisome proliferator-activated receptor gamma coactivator-1alpha interacts with the androgen receptor (AR) and promotes prostate cancer cell growth by activating the AR. Mol Endocrinol 2010; 24:114 - 127; PMID: 19884383; http://dx.doi.org/10.1210/me.2009-0302
   PubMed Web of Science ®Google Scholar
• Cormio A, Guerra F, Cormio G, Pesce V, Fracasso F, Loizzi V, et al. The PGC-1alpha-dependent pathway of mitochondrial biogenesis is upregulated in type I endometrial cancer. Biochem Biophys Res Commun 2009; 390:1182 - 1185; PMID: 19861117; http://dx.doi.org/10.1016/j.bbrc.2009.10.114
   PubMed Web of Science ®Google Scholar
• Škrtic M, Sriskanthadevan S, Jhas B, Gebbia M, Wang X, Wang Z, et al. Inhibition of mitochondrial translation as a therapeutic strategy for human acute myeloid leukemia. Cancer Cell 2011; 20:674 - 688; PMID: 22094260; http://dx.doi.org/10.1016/j.ccr.2011.10.015
   PubMed Web of Science ®Google Scholar
• Järås M, Ebert BL. Power cut: inhibiting mitochondrial translation to target leukemia. Cancer Cell 2011; 20:555 - 556; PMID: 22094249; http://dx.doi.org/10.1016/j.ccr.2011.10.028
   PubMed Web of Science ®Google Scholar
• Casey T, Bond J, Tighe S, Hunter T, Lintault L, Patel O, et al. Molecular signatures suggest a major role for stromal cells in development of invasive breast cancer. Breast Cancer Res Treat 2009; 114:47 - 62; PMID: 18373191; http://dx.doi.org/10.1007/s10549-008-9982-8
   PubMed Web of Science ®Google Scholar
• Ertel A, Dean JL, Rui H, Liu C, Witkiewicz AK, Knudsen KE, et al. RB-pathway disruption in breast cancer: differential association with disease subtypes, disease-specific prognosis and therapeutic response. Cell Cycle 2010; 9:4153 - 4163; PMID: 20948315; http://dx.doi.org/10.4161/cc.9.20.13454
   PubMed Web of Science ®Google Scholar
• Whitaker-Menezes D, Martinez-Outschoorn UE, Lin Z, Ertel A, Flomenberg N, Witkiewicz AK, et al. Evidence for a stromal-epithelial “lactate shuttle” in human tumors: MCT4 is a marker of oxidative stress in cancer-associated fibroblasts. Cell Cycle 2011; 10:1772 - 1783; PMID: 21558814; http://dx.doi.org/10.4161/cc.10.11.15659
   PubMed Web of Science ®Google Scholar